Cumberland Pharmaceuticals (CPIX) Revenue (2010 - 2026)

Cumberland Pharmaceuticals has disclosed Revenue across 17 years of filings, most recently posting $9.1 million for Q1 2026.

• Revenue for Q1 2026 came in at $9.1 million, down 22.04% year-over-year; the trailing twelve-month figure through Mar 2026 was $41.9 million (up 2.08% YoY), and the FY2025 annual result was $44.5 million, up 17.57% from the prior year.
• Revenue came in at $9.1 million for Q1 2026 at Cumberland Pharmaceuticals, down from $13.7 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $13.7 million in Q4 2025 to a low of $8.3 million in Q3 2025.
• The 5-year median for Revenue is $10.1 million (2023), against an average of $10.2 million.
• Across the five-year window, Revenue jumped 41.38% in 2022 and dropped 22.04% in 2026, its largest moves.
• Cumberland Pharmaceuticals' Revenue stood at $9.1 million in 2022, then climbed by 2.51% to $9.4 million in 2023, then grew by 11.57% to $10.4 million in 2024, then jumped by 31.08% to $13.7 million in 2025, then tumbled by 33.24% to $9.1 million in 2026.
• The last three Revenue figures came in at $9.1 million (Q1 2026), $13.7 million (Q4 2025), and $8.3 million (Q3 2025), per Business Quant data.